Single-Center, Randomized, Double-Blind, Placebo-Controlled, Three-Way Crossover Study to Evaluate the Safety, Tolerability and Clinical Activity of a Single Dose of ASM-024 Administered by Inhalation to Subjects With Stable Moderate Asthma.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2012
At a glance
- Drugs ASM 024 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2012 Actual patients number is 20 as reported by ClinicalTrials.gov.
- 25 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.